POMDOCTOR receives Nasdaq notice regarding minimum listing requirements
Digital healthcare provider POMDOCTOR received official notification from the Nasdaq Stock Market on October 28 regarding non compliance with continued listing standards
Pomdoctor, a digital healthcare firm specializing in AI-driven solutions and predictive healthcare, received notice from Nasdaq on October 28, 2026, regarding its failure to meet minimum listing requirements. The company was informed by the Nasdaq Listing Qualifications Department that it no longer fulfills two criteria under Nasdaq Listing Rule 5450: the market value of listed securities (MVLS) of at least $50 million, and the minimum market value of publicly held shares (MVPHS) of $15 million.
Pomdoctor has been given a 180-day window, or until April 26, 2027, to regain compliance. If, at any point during this period, the company's MVLS or MVPHS reaches $50 million or $15 million, respectively, for ten consecutive business days, Nasdaq will confirm compliance, and the matter will be closed. However, if the company fails to regain compliance before the compliance period expires, it may face delisting.
The company is currently evaluating options to comply with the requirements, and there are no assurances that it will meet all Nasdaq's listing criteria during the compliance period.
Written by urgent.news from Vietnam Investment Review's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
